Kirk Allan 4
4 · Eledon Pharmaceuticals, Inc. · Filed Jan 16, 2026
Insider Transaction Report
Form 4
Kirk Allan
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-10+3,430→ 3,430 total - Exercise/Conversion
Restricted Stock Units
[F1]2026-01-10−3,430→ 0 total→ Common Stock (3,430 underlying)
Footnotes (1)
- [F1]Represents shares issuable on settlement of restricted stock units ("RSUs") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026.
Signature
/s/ Paul Little, as attorney-in-fact for Allan Kirk, MD, PhD|2026-01-16